A Cystatin Derived from Fasciola gigantica Suppresses Macrophage-mediated Inflammatory Responses

Authors

  • Pathanin Chantree Division of Anatomy, Department of Preclinical Science, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand
  • Pongsakorn Martviset Division of Parasitology, Department of Preclinical Science, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand
  • Mayuri Tarasuk Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, Thailand

DOI:

https://doi.org/10.14456/2022s10710

Keywords:

Cystatin, Fasciola gigantica, Inflammation, Pro-inflammatory cytokines

Abstract

Introduction: The liver fluke, Fasciola gigantica, can modulate host immune responses through immunomodulatory molecule to retain a suitable environment for its long-term survival. These molecules, such as, cystatin, the cysteine cathepsin inhibitor, etc., may be used for the treatment of human inflammatory diseases.

Objectives: This study aimed to identify the potential of recombinant cystatin from Fasciola gigantica (rFgCyst) whether it can inhibit inflammation mediated by LPS-treated macrophages.

Methods: Mouse macrophage, RAW264.7 cell, and human macrophage, THP-1 cell, were cultured in 96-well plates with various concentration of rFgCyst. Cell viability was determined by MTT assay. For anti-inflammatory assay, RAW264.7 cells and THP-1 cells were treated with rFgCyst for 24 h, followed by inflammation stimulating with LPS (E. coli 0111: B4) and additionally incubating for 12 and 24 h, respectively. After incubation, the culture media and the cells were collected to monitor the levels of pro-inflammatory cytokine including IL6, IL1β, and TNF-α and its mRNAexpression using ELISA, western blot and quantitative real-time RT-PCR (qRT-PCR), respectively.

Results: Pretreatment of RAW264.7 cells and THP-1 cell with rFgCyst inhibited the production of pro‑inflammatory cytokines including IL6, IL1β, and TNF-α induced by LPS both gene and protein expression levels in dose- and time-dependent manner.

Conclusions: rFgCyst reduces inflammation in in vitro model probably by reducing pro-inflammatory cytokines. These results suggest that rFgCyst may have a potential function against human inflammatory diseases in future.

Downloads

Download data is not yet available.

Downloads

Published

2022-08-01

How to Cite

[1]
Chantree, P., Martviset, P. and Tarasuk, M. 2022. A Cystatin Derived from Fasciola gigantica Suppresses Macrophage-mediated Inflammatory Responses. Asian Medical Journal and Alternative Medicine. 22, - (Aug. 2022), S101. DOI:https://doi.org/10.14456/2022s10710.